Y box-binding factor promotes eosinophil survival by stabilizing granulocyte-macrophage colony-stimulating factor mRNA

被引:89
|
作者
Capowski, EE [1 ]
Esnault, S [1 ]
Bhattacharya, S [1 ]
Malter, JS [1 ]
机构
[1] Univ Wisconsin, Sch Med, Dept Pathol & Lab Med, Madison, WI 53792 USA
来源
JOURNAL OF IMMUNOLOGY | 2001年 / 167卷 / 10期
关键词
D O I
10.4049/jimmunol.167.10.5970
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Short-lived peripheral blood eosinophils are recruited to the lungs of asthmatics after allergen challenge, where they become long-lived effector cells central to disease pathophysiology. GM-CSF is an important cytokine which promotes eosinophil differentiation, function, and survival after transit into the lung. In human eosinophils, GM-CSF production is controlled by regulated mRNA stability mediated by the 3 ' untranslated region, AU-rich elements (ARE). We identified human Y box-binding factor I (YB-1) as a GM-CSF mRNA ARE-specific binding protein that is capable of enhancing GM-CSF-dependent survival of eosinophils. Using a transfection system that mimics GM-CSF metabolism in eosinophils, we have shown that transduced YB-I stabilized GM-CSF mRNA in an ARE-dependent mechanism, causing increased GM-CSF production and enhanced in vitro survival. RNA EMSAs indicate that YB-1 interacts with the GM-CSF mRNA through its 3 ' untranslated region ARE. In addition, endogenous GM-CSF mRNA coimmunoprecipitates with endogenous YB-1 protein in activated eosinophils but not resting cells. Thus, we propose a model whereby activation of eosinophils leads to YB-1 binding to and stabilization of GM-CSF mRNA, ultimately resulting in GM-CSF release and prolonged eosinophil survival.
引用
收藏
页码:5970 / 5976
页数:7
相关论文
共 50 条
  • [1] Minute quantities of granulocyte-macrophage colony-stimulating factor prolong eosinophil survival
    Esnault, S
    Malter, JS
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2001, 21 (02): : 117 - 124
  • [2] GLUCOCORTICOIDS INHIBIT EOSINOPHIL RESPONSES TO GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    LAMAS, AM
    LEON, OG
    SCHLEIMER, RP
    JOURNAL OF IMMUNOLOGY, 1991, 147 (01): : 254 - 259
  • [3] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PSORIASIS
    TAKEMATSU, H
    TAGAMI, H
    DERMATOLOGICA, 1990, 181 (01): : 16 - 20
  • [4] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND VASCULITIS
    DREICER, R
    SCHILLER, JH
    CARBONE, PP
    ANNALS OF INTERNAL MEDICINE, 1989, 111 (01) : 91 - 92
  • [5] MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    BURGESS, AW
    NICE, EC
    METHODS IN ENZYMOLOGY, 1985, 116 : 588 - 600
  • [6] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND PSORIASIS
    KELLY, RI
    MARSDEN, RA
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 30 (01) : 144 - 144
  • [7] Functions of granulocyte-macrophage colony-stimulating factor
    Fleetwood, AJ
    Cook, AD
    Hamilton, JA
    CRITICAL REVIEWS IN IMMUNOLOGY, 2005, 25 (05) : 405 - 428
  • [8] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN NEUTROPENIA
    HOGAN, KR
    PETERS, MD
    DICP-THE ANNALS OF PHARMACOTHERAPY, 1991, 25 (01): : 32 - 35
  • [9] Effect of desloratadine on epithelial cell granulocyte-macrophage colony-stimulating factor secretion and eosinophil survival
    Mullol, J
    Roca-Ferrer, J
    Alobid, I
    Pujols, L
    Valero, A
    Xaubet, A
    Bernal-Sprekelsen, M
    Picado, C
    CLINICAL AND EXPERIMENTAL ALLERGY, 2006, 36 (01): : 52 - 58
  • [10] HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    GASSON, JC
    NIMER, SD
    DIPERSIO, JF
    BALDWIN, GC
    WEISBART, RH
    GOLDE, DW
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 178 - 178